About 150 years ago, Louis Pasteur discovered that transmissible diseases and epidemics are caused by microbes or even subcellular infectious agents, later on called viruses.
The first methods to detect and to identify those agents were microscopy, animal experiments or voluntary self infections of scientists. Pasteur, Robert Koch and others developed a lot of methods to cultivate, to isolate and to identify bacteria in special bouillons, agar dishes, methods, which have been continuously improved and optimized up to date. In virology, a first breakthrough in the diagnostic technology of infectious diseases was the development of embryonated chicken eggs as the smallest system of animal experiments in the thirties of the last century and the advent of cell cultures in the subsequent decade.
For the next three decades, cell culture technology was the basis of diagnostic virology in terms of three aspects:
• By the use of cell culture technology, many viruses were isolated and propagated in large amounts.
• This opened up the closer research on viruses and supported the development of antivirals and vaccines.
• Cell culture technology provides antigens for the antibody detection and for immunization of animals to produce specific antibodies for antigen detection (serology).
But there were three disadvantages:
• Tests of molecular biologic diagnostics are methods to determine genomic nucleic acid of the infectious agents or of transcribed mRNA.
Since 1970, those tests were developed using the avidity between the strands in genomic DNA for diagnostic approaches similar to the avidity between antigen and antibody. The first tests were developed to detect nonculturable viruses either in blood or other fluid samples (e.g., dot blot hybridization of hepatitis B virus DNA) in organ tissue samples (e.g., in situ hybridization of oncogenic DNA viruses). Apart from hybridization, viral DNA or RNA electrophoresis was applied: Electrophore typing of segmented virus RNA genome (e.g., rotavirus) and restriction fragment length polymorphism (RFLP) of DNA viruses (and of cDNA from RNA viruses) proved of value as simple tools of molecular epidemiology and tracing infection chains.
Those tests were widely distributed. However, their sensitivity was not satisfying.
A [1] . Among them, the real time PCR has achieved highest relevance in diagnostic virology. In this method, the reaction kinetics is faithfully determined during the hybridization cycles by release of defined signal-emitting gene probes. As a consequence, the relative amount of viral genomes can be calculated. In blood (plasma) samples, the viraemia can be quantified. The advantages of PCR compared to the conventional cell culture-based methods of virus detection are as follows:
• Detection and counting of non-or not easily culturable viruses (e.g., HBV, HCV, HIV) • Rapid pathognomonic test results in special specimens, e.g., CSF for the diagnosis of neurotropic virus infections • Reduced problems of specimen sampling and transport in comparison to virus isolation procedure • Superior turnaround time (results are achieved in hours instead of days) without significant loss of sensitivity or specificity compared to conventional virus isolation procedures • Superior specificity compared to other rapid tests (antigen, EM) • Quantification of viraemia as a marker of pathogenicity and therapy control (e.g., HIV, HCV, CMV) • Superior management in hygiene and epidemiology:
• Genotyping by rapid nucleic acid sequencing, • Exclusion of infectious risks A main advantage is virus detection and quantification in the pathologic material, e.g., in bronchial lavages of patients suffering from pneumonia. On the other side, sometimes the etiologic relevance is questionable in terms of what is the hen (infectious etiology)? What is the egg (secondary reactivation)? [2] .
A second break-through in viral diagnostics was achieved by the advent of automated methods of DNA sequencing which have replaced all former methods to identify and characterize a virus and track infection chains [3] . Modern methods of ''next generation sequencing'' have revolutionized genetics and provide information on viral and microbial pathogenicity [4] .
This was of particular importance in the management of HIV diseases since the advent of multiple anti-retroviral drugs. However, new technologies produce new problems, too.
• Problems related to high sensitivity: ''more results than symptoms!'' (definition of cut-off lines is needed in terms of clinical relevance) • Analysis of therapy resistance by viral genotyping has to be based on data bases and requires computer analysis, while conventional phenotyping provides reliable results in individual cases, but is timeconsuming.
• The determination of disinfectant or antiviral drug activity and of neutralizing/protecting antibodies cannot do without biologic technologies to assess reduction in infectivity
In summary, molecular methods have replaced biologic methods in many aspects of routine diagnostics of infectious diseases. However, in special cases, conventional methods remain useful or even essential (cell culture technology, hemagglutination, and electron microscopy).
